April 5, 2021 – The Bowdoin Group has placed two key leaders for Genome Medical in South San Francisco, CA. Russell Glass, CEO of on-demand mental health company Ginger, becomes an independent director for the company, and Brandon Poe, who comes to the business from Illumina, was named CFO. Genome Medical is accelerating the availability, efficiency, and effectiveness of genomic insights as a service. “Congratulations to Brandon, Russ and the entire team at Genome Medica,” said Josh Gottlieb, managing director, digital health, for The Bowdoin Group, who served as one of the primary search leads. “Brandon brings extensive experience growing finance functions within the healthcare space as their new CFO, and Russ brings a wealth of knowledge around scaling businesses as a career CEO as the newest to their board of directors. With their collective expertise and clear passion for revolutionizing patient care, I’m confident they will both have a significant impact on Genome Medical’s future growth.”
“This added expertise will help propel our company forward as a leader in efficient, on-demand genomics care and as an innovator in the technology-driven delivery of genomic insights as a service,” said Lisa Alderson, CEO and co-founder of Genome Medical. Mr. Glass joins a board led by Genome Medical co-founder and chairman Randy Scott, with members and observers representing the company’s co-founders and its strategic investors. Mr. Glass, as…
